# SightLine Partners

SightLine Partners is a Private Equity based in Bloomington, United States.

## Overview

- **Organization type:** Private Equity
- **Headquarters:** Bloomington, United States
- **Region:** North America
- **Address:** Bloomington, MN, United States
- **Founded:** 2004
- **Assets under management:** Undisclosed
- **Website:** www.sightlinepartners.com
- **LinkedIn:** https://www.linkedin.com/company/sightline-partners

## Regulatory record

- **CRD number:** 162629
- **SEC file number:** 801-80007
- **Registration status:** Registered
- **Reports private funds:** Yes
- **IAPD record:** https://adviserinfo.sec.gov/firm/summary/162629

## About

SightLine Partners is an SEC-registered investment adviser in Bloomington, MN, registered since 2014. The firm manages approximately $567 million in regulatory assets. It has 7 employees and 5 investment advisers.

## Sectors

- Healthcare Services
- Digital Health

## People

- Buzz Benson — Managing Director & Co-Founder
- Kyle Armstrong — Director

## Questions

### Does SightLine Partners operate as a generalist secondary firm or a healthcare specialist?

SightLine is exclusively a healthcare specialist. Its entire mandate covers medical devices, diagnostics, digital health, and healthcare services. Unlike broad secondary platforms that buy LP stakes across all sectors, SightLine only transacts where its team has operating and clinical-domain expertise, which the firm argues produces better underwriting on regulatory and reimbursement risk.

### How does SightLine source its direct secondary deals?

SightLine's deal flow comes from being a known specialist in a narrow niche. When venture capital firms managing older med-tech funds face LP pressure to wind down, SightLine is a natural call. The firm also sources through its network of healthcare executives and its own portfolio company boards, which generate visibility into distressed cap tables before processes go broad.

### Does SightLine manage only blind-pool funds or does it use other structures?

SightLine's primary vehicle is a committed blind-pool fund series, but its direct secondary focus means it frequently transacts outside the auction processes common in large LP-stake trades. The firm can structure bespoke vehicles for single-asset GP-led recapitalizations, a capability that gives it flexibility when founders or management teams want to buy out legacy venture investors and bring in a committed healthcare backer.

### Where does SightLine invest geographically?

The firm's healthcare focus is North American, with a historical concentration in the Upper Midwest — particularly Minnesota's dense medical-device corridor — and California. SightLine will invest nationally where the sector thesis holds, but its Bloomington headquarters gives it deep connectivity to the engineering and clinical talent pool around Minneapolis-St. Paul.

### Is SightLine Partners currently investing out of a specific fund?

Yes. In October 2024, the firm announced the final close of SightLine Healthcare Fund IV at $305 million, exceeding its $250 million target. As of early 2026, the fund is actively deploying capital into both secondary purchases and growth-stage healthcare investments.

## Related profiles

- [SigFig Wealth Management](https://altss.com/profile/sigfig-wealth-management)
- [Sigitech Holdings](https://altss.com/profile/sigitech-holdings)

---

Last updated: 2026-06-03T20:00:00.000Z

Canonical page: https://altss.com/profile/sightline-partners

Maintained by Altss — https://altss.com — methodology: https://altss.com/methodology